Vaxigen International Research Center Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 10.00 K
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
About Vaxigen International Research Center
Vaxigen International Research Center Private Limited (VIRCPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 May 2021 (Three years and nine months 5 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Kaavya Nair, Anburaju Sasikala, and Johnson Samuel serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100TZ2021PTC036150
-
Company No.
036150
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 May 2021
-
Date of AGM
09 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Vaxigen International Research Center?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaavya Nair
|
Managing Director | 04-May-2021 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Anburaju Sasikala
|
Director | 04-May-2021 | Current |
|
Johnson Samuel
|
Director | 04-May-2021 | Current |
Financial Performance of Vaxigen International Research Center.
Vaxigen International Research Center Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaxigen International Research Center?
Unlock access to Vaxigen International Research Center's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vaxigen International Research Center?
Unlock and access historical data on people associated with Vaxigen International Research Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaxigen International Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaxigen International Research Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.